Pressman M R, Peterson D D, Meyer T J, Harkins J P, Gurijala L
Sleep Disorders Center, Lankenau Hospital and Medical Research Center, Wynnewood, Pennsylvania 19096-3498, USA.
Am J Respir Crit Care Med. 1995 May;151(5):1632-4. doi: 10.1164/ajrccm.151.5.7735625.
Administration of nasal continuous positive airway pressure (NCPAP) is the treatment of choice for most patients with obstructive sleep apnea. Many patients experience side effects with NCPAP use, and the compliance rate is reported to vary between 46-89%. The ramp is a device found on many NCPAP machines that resets the pressure to 3 cm H2O and then slowly increases the pressure to the prescribed pressure over a period of up to 45 min. The ramp allows patients time to fall asleep before the higher and likely more uncomfortable prescribed pressure is administered. We present a case in which a patient's repeated remote-controlled activation of this ramping feature severely limited effective therapy even when the NCPAP mask was properly in place, the machine was on, and the patient was breathing nasally.
鼻持续气道正压通气(NCPAP)治疗是大多数阻塞性睡眠呼吸暂停患者的首选治疗方法。许多患者在使用NCPAP时会出现副作用,据报道其依从率在46%至89%之间。斜坡功能是许多NCPAP机器上都有的一个装置,它将压力重置为3厘米水柱,然后在长达45分钟的时间内将压力缓慢增加到规定压力。斜坡功能使患者有时间在施加更高且可能更不舒服的规定压力之前入睡。我们报告一例患者的情况,即使NCPAP面罩佩戴正确、机器开启且患者经鼻呼吸,患者反复通过遥控激活此斜坡功能仍严重限制了有效治疗。